You are here: Home » Companies » News
Nayara Energy's India fuel retail outlets triple in 5 years to reach 6,000
Sundaram Finance Q3 profit up 45% to Rs 242 cr, disbursements up 8%
Business Standard

Zydus Cadila's Q3 net up 41% to Rs 527 cr on strong India biz growth

US formulations business dips 4% with revenues at Rs 1,603 cr, Q3 sees Zydus file 10 additional ANDAs with US FDA, taking total filings to 410

Topics
Zydus Cadila | Q3 results | Pharma Companies

Vinay Umarji  |  Ahmedabad 



pharmacy, drugs, medicine, pharma companies, pharmaceuticals, vaccine, coronavirus, covid, testing
Consolidated revenue from operations grew 6.2 per cent in Q3 of FY21 to Rs 3753.7 crore

Led by double-digit growth in its India business, Ahmedabad-based drug maker Cadila Healthcare Ltd (Zydus Cadila) has seen its consolidated net profit rise 41 per cent at Rs 527.2 crore in the third quarter ended December 30, 2020.

TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.

SUBSCRIBE TO INSIGHTS

What you get on Business Standard Premium?

  • icon Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • icon Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • icon Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
  • icon Pick your 5 favourite companies, get a daily email with all news updates on them.
  • icon 26 years of website archives.
  • icon Preferential invites to Business Standard events.

OR


Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.

Download the Business Standard App for latest Business News and Market News .

First Published: Fri, February 05 2021. 15:13 IST

RECOMMENDED FOR YOU

.